Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus

Journal of Virology

Volumn 82, Issue 3, 2008, Pages 1332-1338

  Hooper, Jay W ^a   Ferro, Anthony M ^a   Wahl Jensen, Victoria ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; DNA VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BITE; BUNYAVIRUS; CONTAMINATION; CONTROLLED STUDY; DNA IMMUNIZATION; FEMALE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; INGESTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT; SYRIAN HAMSTER; TECHNOLOGY; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; CRICETINAE; FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; IMMUNIZATION, PASSIVE; LETHAL DOSE 50; MALE; MESOCRICETUS; NEUTRALIZATION TESTS; RABBITS; VACCINES, DNA;

ANDES VIRUS; BUNYAVIRIDAE; CRICETINAE; HANTAVIRUS; MESOCRICETUS AURATUS; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 38349094261     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01822-07     Document Type: Article

References (28)

1. Avila, M. M., S. R. Samoilovich, R. P. Laguens, M. S. Merani, and M. C. Weissenbacher. 1987. Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurologic signs. J. Med. Virol. 21:67-74.
2. Bharadwaj, M., R. Nofchissey, D. Goade, F. Koster, and B. Hjelle. 2000. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J. Infect. Dis. 182:43-48.
3. Butler, J. C., and C. J. Peters. 1994. Hantaviruses and hantavirus pulmonary syndrome. Clin. Infect. Dis. 19:387-394.
4. Campen, M. J., M. L. Milazzo, C. F. Fulhorst, C. J. Obot Akata, and F. Koster. 2006. Characterization of shock in a hamster model of hantavirus infection. Virology 356:45-49.
5. Crowe, J. E., Jr., B. R. Murphy, R. M. Chanock, R. A. Williamson, C. F. Barbas III, and D. R. Burton. 1994. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. USA 91:1386-1390.
6. Custer, D. M., E. Thompson, C. S. Schmaljohn, T. G. Ksiazek, and J. W. Hooper. 2003. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J. Virol. 77:9894-9905.
7. Enria, D., P. Padula, E. L. Segura, N. Pini, A. Edelstein, C. R. Posse, and M. C. Weissenbacher. 1996. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (Buenos Aires) 56:709-711.
8. Ferres, M., P. Vial, C. Marco, L. Yanez, P. Godoy, C. Castillo, B. Hjelle, I. Delgado, S. J. Lee, and G. J. Mertz. 2007. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. J. Infect. Dis. 195:1563-1571.
9. Hooper, J. W., D. M. Custer, J. Smith, and V. Wahl-Jensen. 2006. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 347:208-216.
10. Hooper, J. W., D. M. Custer, E. Thompson, and C. S. Schmaljohn. 2001. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J. Virol. 75:8469-8477.
11. Hooper, J. W., K. I. Kamrud, F. Elgh, D. Custer, and C. S. Schmaljohn. 1999. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 255:269-278.
12. Hooper, J. W., T. Larsen, D. M. Custer, and C. S. Schmaljohn. 2001. A lethal disease model for hantavirus pulmonary syndrome. Virology 289:6-14.
13. Hooper, J. W., and D. Li. 2001. Vaccines against hantaviruses. Curr. Top. Microbiol. Immunol. 256:171-191.
14. Khan, A. S., T. G. Ksiazek, and C. J. Peters. 1996. Hantavirus pulmonary syndrome. Lancet 347:739-741.
15. Lazaro, M. E., G. E. Cantoni, L. M. Calanni, A. J. Resa, E. R. Herrero, M. A. Iacono, D. A. Enria, and S. M. Gonzalez Cappa. 2007. Clusters of hantavirus infection, southern Argentina. Emerg. Infect. Dis. 13:104-110.
16. Lee, H. W., P. W. Lee, and K. M. Johnson. 1978. Isolation of the etiologic agent of Korean hemorrhagic fever. J. Infect. Dis. 137:298-308.
17. Lopez, N., P. Padula, C. Rossi, M. E. Lazaro, and M. T. Franze-Fernandez. 1996. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220:223-226.
18. Lopez, N., P. Padula, C. Rossi, S. Miguel, A. Edelstein, E. Ramirez, and M. T. Franze-Fernandez. 1997. Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile. Virus Res. 50:77-84.
19. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
20. Padula, P. J., A. Edelstein, S. D. Miguel, N. M. Lopez, C. M. Rossi, and R. D. Rabinovich. 1998. Epidemic outbreak of hantavirus pulmonary syndrome in Argentina. Molecular evidence of person to person transmission of Andes virus. Medicina (Buenos Aires) 58(Suppl. 1):27-36.
21. Padula, P. J., A. Edelstein, S. D. Miguel, N. M. Lopez, C. M. Rossi, and R. D. Rabinovich. 1998. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241:323-330.
22. Peters, C. J., and A. S. Khan. 2002. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin. Infect. Dis. 34:1224-1231.
23. Rollin, P. E., T. G. Ksiazek, L. H. Elliott, E. V. Ravkov, M. L. Martin, S. Morzunov, W. Livingstone, M. Monroe, G. Glass, S. Ruo, et al. 1995. Isolation of black creek canal virus, a new hantavirus from Sigmodon hispidus in Florida. J. Med. Virol. 46:35-39.
24. Schmaljohn, A. L., D. Li, D. L. Negley, D. S. Bressler, M. J. Turell, G. W. Kerch, M. S. Ascher, and C. S. Schmaljohn. 1995. Isolation and initial characterization of a newfound hantavirus from California. Virology 206:963-972.
25. St. Jeor, S. C. 2004. Three-week incubation period for hantavirus infection. Pediatr. Infect. Dis. J. 23:974-975.
26. Toro, J., J. D. Vega, A. S. Khan, J. N. Mills, P. Padula, W. Terry, Z. Yadon, R. Valderrama, B. A. Ellis, C. Pavletic, R. Cerda, S. Zaki, W. J. Shieh, R. Meyer, M. Tapia, C. Mansilla, M. Baro, J. A. Vergara, M. Concha, G. Calderon, D. Enria, C. J. Peters, and T. G. Ksiazek. 1998. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg. Infect. Dis. 4:687-694.
27. Vial, P. A., F. Valdhieso, G. Mertz, C. Castillo, E. Belmar, I. Delgado, M. Tapia, and M. Ferres. 2006. Incubation period of hantavirus cardiopulmonary syndrome. Emerg. Infect. Dis. 12:1271-1273.
28. Wells, R. M., S. Sosa Estani, Z. E. Yadon, D. Enria, P. Padula, N. Pini, J. N. Mills, C. J. Peters, and E. L. Segura. 1997. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg. Infect. Dis. 3:171-174.